Lilly   2Q Revenues: $5.6 billion (-10%)   2Q Earnings: $923.6 million (-23%)   YTD Revenues: $11.2 billion (-7%)   YTD Earnings: $1.9 billion (-14%)   Comments: U.S. sales were down 10% to $3.0 billion and revenue outside the U.S. was down 11% to $2.6 billion due to the loss of patent exclusivity for Zyprexa (-73%). Cymbalta revenue increased 22% to $1.2 billion. Alimta sales were $659.5million (+8%). Humalog sales were $613.4 million (+4%). Cialis sales were down 2% to $469.5 million. Forteo s...